EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.3.1.87 | Acidosis |
17429052 |
Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells. |
therapeutic application
unassigned |
2
0 |
| 2.3.1.87 | Acidosis |
18650482 |
Inhibition of SNAT2 by metabolic acidosis enhances proteolysis in skeletal muscle. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
2
3
0 |
| 2.3.1.87 | Acquired Immunodeficiency Syndrome |
26439863 |
Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. |
unassigned |
0 |
| 2.3.1.87 | aralkylamine n-acetyltransferase deficiency |
11316327 |
Prolonged swim-test immobility of serotonin N-acetyltransferase (AANAT)-mutant mice. |
causal interaction
unassigned |
4
0 |
| 2.3.1.87 | aralkylamine n-acetyltransferase deficiency |
31552299 |
Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 2.3.1.87 | Arthus Reaction |
2136904 |
Serotonin metabolism in the arthus reaction. |
ongoing research
unassigned |
3
0 |
| 2.3.1.87 | Asthma |
18680475 |
N-acetyltransferases as markers for asthma and allergic/atopic disorders. |
causal interaction
unassigned |
4
0 |
| 2.3.1.87 | Astrocytoma |
15094455 |
Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 2.3.1.87 | Brain Injuries |
28502584 |
Up-regulation of miR-325-3p suppresses pineal aralkylamine N-acetyltransferase (Aanat) after neonatal hypoxia-ischemia brain injury in rats. |
causal interaction
unassigned |
2
0 |
| 2.3.1.87 | Brain Neoplasms |
15094455 |
Increased expression of a glutamine transporter SNAT3 is a marker of malignant gliomas. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
